Information on the Target
mydentist is the UK’s largest provider of affordable dentistry, operating over 500 dental practices across the country and serving approximately four million patients each year. The Company offers a range of dental services categorized into three tiers: NHS dental care, myoptions private care, and Premium private care. As the leading dental provider by revenue, practices, and clinicians in the UK, mydentist boasts a workforce of over 3,500 dental professionals and more than 2,500 surgeries.
In recent years, mydentist has experienced robust performance, largely attributed to enhanced access to affordable care for both NHS and private patients. Furthermore, investments in digital infrastructure and a commitment to establishing the UK's foremost dental practice network have bolstered the Company’s growth trajectory.
Industry Overview in the UK
The dental services sector in the UK is experiencing significant transformation, driven by rising demand for accessible dental care and innovative treatments that cater to diverse patient needs. The growing emphasis on oral health awareness among the population propels the market forward, creating opportunities for dental providers to expand their services.
With increasing government initiatives aimed at improving NHS dental services, there has been a push towards greater investment in the dental industry. This includes providing more resources for dental practices and enhancing the quality of care delivered to patients, which is critical in meeting the needs of an evolving patient demographic.
The introduction of digital technologies in dentistry has also played a pivotal role in shaping the industry. Practices are increasingly leveraging digital tools for patient management, treatment planning, and record-keeping, leading to improved clinical outcomes and enhanced patient experiences, thereby fueling further growth in the sector.
As patients demand higher quality from their dental care providers, competition in the industry intensifies, resulting in a surge of consolidation efforts. Companies like mydentist, which focus on streamlining operations and enhancing service offerings, are well-positioned to lead the market in this dynamic landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The recent sale of Palamon Capital Partners’ majority stake in mydentist to Bridgepoint is a culmination of a strategic partnership aimed at enhancing the Company’s operational capabilities and market position. Following Palamon’s acquisition in 2021, their collaboration with the management team has yielded significant improvements, such as the divestment of non-core businesses, which allowed mydentist to concentrate solely on dental services.
This divestment not only reduced leverage but also freed up capital that could be reinvested into the business, facilitating advancements in infrastructure and stimulating growth. The resulting value creation and organic EBITDA growth demonstrate the effectiveness of this strategy, making the company an attractive investment opportunity for Bridgepoint.
Information About the Investor
Bridgepoint is a leading private equity firm with substantial expertise in investing in growth-oriented businesses across various sectors. Their strategic focus on expanding market leaders aligns well with mydentist’s vision of offering high-quality, accessible dental care. With a robust track record of supporting companies in their growth journeys, Bridgepoint is well-positioned to assist mydentist in accelerating its next phase of expansion.
The firm’s extensive resources and industry knowledge are expected to enhance mydentist's operational efficiencies and foster innovation, particularly through digital advancements aimed at improving patient care and optimizing clinical outcomes. This partnership signifies Bridgepoint's commitment to investing in the dental sector, recognizing the potential for continued growth and profitability.
View of Dealert
The recent acquisition of mydentist by Bridgepoint presents a promising opportunity for both parties. The strategic initiatives implemented by Palamon during their tenure, such as enhancing service quality and operational efficiency, have established a solid foundation for future growth. The divestment of the DD Group enabled mydentist to focus exclusively on its core dental services, making it a more streamlined and agile entity.
Bridgepoint’s decision to invest indicates confidence in mydentist's ability to lead the market in affordable dentistry in the UK, particularly as the demand for accessible dental care continues to rise. The combination of mydentist's established presence and Bridgepoint's resources could catalyze significant market growth and better patient experiences.
Furthermore, mydentist's commitment to digital innovation and operational excellence under the new partnership is likely to enhance both patient satisfaction and clinical outcomes, positioning the company favorably within the competitive dental landscape. Overall, this transaction could prove to be a beneficial investment that aligns with current trends and market demands.
In conclusion, given the strategic alignment and growth potential, this deal appears to be a strong investment, positioning mydentist well for continued success in the evolving UK dental market.
Similar Deals
Asker Healthcare Group → Hospital Services Limited
2025
Sycamore Partners → Walgreens Boots Alliance’s UK-based pharmacy chain
2025
Grosvenor Health and Social Care → Esteem Care Holdings Ltd.
2024
Optimo Care Group → My Life Choice Limited
2023
Bridgepoint Advisers Limited
invested in
mydentist
in 2025
in a Buyout deal